NASDAQ : ALGN
Align Technology, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 149.89 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 10.65B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 10.65B |
| Enterprise Value | 9.62B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 71.04M |
| Shares Outstanding | 71.04M |
| Shares Change (YoY) | -2.39% |
| Shares Change (QoQ) | -0.71% |
| Owned by Insiders (%) | 3.42% |
| Owned by Institutions (%) | 102.97% |
| Float | 66.84M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 21.82 |
| Forward PE | 12.58 |
| PS Ratio | 2.56 |
| Forward PS | 2.55 |
| PB Ratio | 2.47 |
| P/TBV Ratio | 2.86 |
| P/FCF Ratio | 16.45 |
| P/OCF Ratio | 14.20 |
| PEG Ratio | 1.32 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 19.55 |
| EV / Sales | 2.31 |
| EV / EBITDA | 10.08 |
| EV / EBIT | 11.89 |
| EV / FCF | 14.85 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.42 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.17 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 11.91% |
| Return on Assets (ROA) | 7.93% |
| Return on Invested Capital (ROIC) | 18.93% |
| Return on Capital Employed (ROCE) | 17.56% |
| Weighted Average Cost of Capital (WACC) | 13.67% |
| Revenue Per Employee | $203,504 |
| Profits Per Employee | $24,070 |
| Employee Count | 20,435 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 5.26 |
Taxes
| Measure | Value |
|---|
| Income Tax | 152.38M |
| Effective Tax Rate | 23.65% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.74 |
| 52-Week Price Change | +13.63% |
| 50-Day Moving Average | 150.46 |
| 200-Day Moving Average | 168.82 |
| Relative Strength Index (RSI) | 49.81 |
| Average Volume (20 Days) | 1,058,918 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.15M |
| Short Previous Month | 4.20M |
| Short % of Shares Out | 5.84% |
| Short % of Float | 6.20% |
| Short Ratio (days to cover) | 4.57 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.16B |
| Gross Profit | 2.97B |
| Operating Income | 808.79M |
| Pretax Income | 644.25M |
| Net Income | 491.87M |
| EBITDA | 954.18M |
| EBIT | 808.79M |
| Earnings Per Share (EPS) | $6.87 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.14B |
| Total Debt | 112.30M |
| Net Cash | 1.03B |
| Net Cash Per Share | $14.54 |
| Equity (Book Value) | 4.31B |
| Book Value Per Share | 60.65 |
| Working Capital | 812.58M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 749.89M |
| Capital Expenditures | -102.45M |
| Depreciation & Amortization | 145.39M |
| Net Borrowing | n/a |
| Free Cash Flow | 647.45M |
| FCF Per Share | $9.11 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.34% |
| Operating Margin | 19.45% |
| Pretax Margin | 15.49% |
| Profit Margin | 11.83% |
| EBITDA Margin | 22.94% |
| EBIT Margin | 19.45% |
| FCF Margin | 15.57% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.39% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.58% |
| FCF Yield | 6.08% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $186.50 |
| Price Target Difference | 24.43% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 3.25% |
| EPS Growth Forecast (3Y) | 8.48% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |